Venerito V, Fornaro M, Sabbagh S, Ghosh S, Chinoy H, Gupta L, MyoLLM investigators\n. Integrating Large Language Models in Medicine: A Study of Claude 2\'s Performance in MDAAT Scoring for idiopathic inflammatory myopathies. Rheumatology (Oxford). 2024 Apr 22 PMID: 38648744 04/23/2024
Karasawa R, Yudoh K, Sato T, Tanaka M, Sabbagh SE, Flegel WA, Mammen AL, Jarvis JN, Rider LG, Childhood Myositis Heterogeneity Study Group. Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis. Rheumatology (Oxford). 2023 Nov 02;62(11):3757-3762 PMID: 37144941 PMCID: PMC10629777 05/05/2023
Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, Pak K, Kishi T, Flegel WA, Targoff IN, Miller FW, Lundberg IE, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI226-SI234 PMID: 35961028 PMCID: PMC9949705 08/13/2022
Karasawa R, Yudoh K, Sato T, Tanaka M, Tamaki M, Sabbagh SE, O\'Hanlon TP, Noroozi-Farhadi P, Targoff IN, Flegel WA, Mammen AL, Miller FW, Hicar MD, Rider LG, Jarvis JN. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Rheumatology (Oxford). 2022 Jul 06;61(7):2969-2977 PMID: 34791087 PMCID: PMC9258543 11/19/2021
Pinal-Fernandez I, Pak K, Gil-Vila A, Baucells A, Plotz B, Casal-Dominguez M, Derfoul A, Martinez-Carretero MA, Selva-O\'Callaghan A, Sabbagh S, Casciola-Rosen L, Albayda J, Paik J, Tiniakou E, Danoff SK, Lloyd TE, Miller FW, Rider LG, Christopher-Stine L, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group. Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. Arthritis Rheumatol. 2022 Feb;74(2):358-364 PMID: 34313394 PMCID: PMC8792092 07/28/2021
Sabbagh SE, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik JJ, Miller FW, Rider LG, Mammen AL, Christopher-Stine L, Johns Hopkins Myositis Center Group. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Clin Rheumatol. 2021 Oct;40(10):4095-4100 PMID: 33851273 PMCID: PMC8463345 04/15/2021
Sabbagh SE, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, Pinal-Fernandez I, Roberts J, Rouster-Stevens K, Schmeling H, Sura A, Tarshish G, Tucker L, Rider LG, Kim S, CARRA JDM Workgroup and the Childhood Myositis Heterogeneity Study Group. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. Rheumatology (Oxford). 2021 Feb 01;60(2):829-836 PMID: 32889531 PMCID: PMC7850515 09/06/2020
Sabbagh S, Almeida de Jesus A, Hwang S, Kuehn HS, Kim H, Jung L, Carrasco R, Rosenzweig S, Goldbach-Mansky R, Rider LG. Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain. 2019 Nov 01;142(11):e59 PMID: 31603187 PMCID: PMC6821280 10/12/2019
Sabbagh S, Pinal Fernandez I, Miller FW, Rider LG, Mammen AL. Response to: \'Comment on: \'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis\' by Sabbagh S et al\' by Yang et al. Ann Rheum Dis. 2020 Aug;79(8):e97 PMID: 31208959 PMCID: PMC8466717 06/19/2019
Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019 Jul;78(7):988-995 PMID: 31018961 PMCID: PMC7570952 04/26/2019